During the last three months, 4 analysts shared their evaluations of Patterson Cos (NASDAQ:PDCO), revealing diverse outlooks from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $23.75, with a high estimate of $25.00 and a low estimate of $22.00. A decline of 6.86% from the prior average price target is evident in the current average.

Diving into Analyst Ratings: An In-Depth Exploration

An in-depth analysis of recent analyst actions unveils how financial experts perceive Patterson Cos. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Patterson Cos's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Patterson Cos analyst ratings.

Get to Know Patterson Cos Better

A Deep Dive into Patterson Cos's Financials

Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

Revenue Challenges: Patterson Cos's revenue growth over 3 months faced difficulties. As of 31 July, 2024, the company experienced a decline of approximately -2.22%. This indicates a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Patterson Cos's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 0.89%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Patterson Cos's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.4%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Patterson Cos's ROA excels beyond industry benchmarks, reaching 0.48%. This signifies efficient management of assets and strong financial health.

Debt Management: Patterson Cos's debt-to-equity ratio is below the industry average. With a ratio of 0.94, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Analyst Ratings: Simplified

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.